Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16983 | 624 | 41.2 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2447 | 2 | DYSFIBRINOGENEMIA//AFIBRINOGENEMIA//FIBRINOGEN | 4049 |
16983 | 1 | THROMBOCYTOSIS//SERUM FIBRINOGEN//PREOPERATIVE PLATELET COUNT | 624 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | THROMBOCYTOSIS | authKW | 927633 | 15% | 20% | 95 |
2 | SERUM FIBRINOGEN | authKW | 156586 | 1% | 80% | 4 |
3 | PREOPERATIVE PLATELET COUNT | authKW | 146801 | 0% | 100% | 3 |
4 | INT CARDIOVASC MED | address | 97867 | 0% | 100% | 2 |
5 | PLATELET MEGAKARYOCYTE GRP | address | 97867 | 0% | 100% | 2 |
6 | SOLID PHASE VON WILLEBRAND FACTOR | authKW | 97867 | 0% | 100% | 2 |
7 | PLATELETS | authKW | 89690 | 24% | 1% | 149 |
8 | PLASMA FIBRINOGEN | authKW | 68323 | 1% | 16% | 9 |
9 | ELEVATED PLATELET COUNT | authKW | 65243 | 0% | 67% | 2 |
10 | SECT CARDIOVASC PHARMACOL SCI | address | 62911 | 0% | 43% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 3567 | 40% | 0% | 247 |
2 | Hematology | 3117 | 22% | 0% | 137 |
3 | Peripheral Vascular Diseases | 869 | 12% | 0% | 72 |
4 | Obstetrics & Gynecology | 316 | 8% | 0% | 47 |
5 | Medicine, Research & Experimental | 125 | 6% | 0% | 40 |
6 | Cell Biology | 71 | 8% | 0% | 47 |
7 | Gastroenterology & Hepatology | 63 | 4% | 0% | 24 |
8 | Surgery | 60 | 8% | 0% | 47 |
9 | Pharmacology & Pharmacy | 31 | 7% | 0% | 43 |
10 | Urology & Nephrology | 28 | 3% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INT CARDIOVASC MED | 97867 | 0% | 100% | 2 |
2 | PLATELET MEGAKARYOCYTE GRP | 97867 | 0% | 100% | 2 |
3 | SECT CARDIOVASC PHARMACOL SCI | 62911 | 0% | 43% | 3 |
4 | SECT BENIGN HEMATOL | 55918 | 1% | 29% | 4 |
5 | AEGEAN MATERN TEACHING HOSP | 48934 | 0% | 100% | 1 |
6 | BIOL CELLULAIREUNITE MICROSCOPIE ELECT | 48934 | 0% | 100% | 1 |
7 | CARDIOL UNIT MED SOLNA | 48934 | 0% | 100% | 1 |
8 | CARDIOVASC MED CLIN PATHOL CLIN GENET | 48934 | 0% | 100% | 1 |
9 | CELLUAR MOL IMMUNOL | 48934 | 0% | 100% | 1 |
10 | CLIN COOPERAT GRP TUMOR THER Y HYPERTHENNIA | 48934 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PLATELETS | 5621 | 2% | 1% | 14 |
2 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2794 | 2% | 0% | 15 |
3 | THROMBOSIS AND HAEMOSTASIS | 2348 | 4% | 0% | 22 |
4 | CLINICAL & EXPERIMENTAL METASTASIS | 1556 | 1% | 0% | 8 |
5 | JOURNAL OF TRADITIONAL CHINESE MEDICINE | 1039 | 1% | 1% | 4 |
6 | BLOOD | 1001 | 4% | 0% | 27 |
7 | BMC CANCER | 954 | 2% | 0% | 12 |
8 | THROMBOSIS RESEARCH | 915 | 2% | 0% | 14 |
9 | CURRENT PROTEOMICS | 825 | 0% | 1% | 2 |
10 | GYNECOLOGIC ONCOLOGY | 822 | 2% | 0% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | THROMBOCYTOSIS | 927633 | 15% | 20% | 95 | Search THROMBOCYTOSIS | Search THROMBOCYTOSIS |
2 | SERUM FIBRINOGEN | 156586 | 1% | 80% | 4 | Search SERUM+FIBRINOGEN | Search SERUM+FIBRINOGEN |
3 | PREOPERATIVE PLATELET COUNT | 146801 | 0% | 100% | 3 | Search PREOPERATIVE+PLATELET+COUNT | Search PREOPERATIVE+PLATELET+COUNT |
4 | SOLID PHASE VON WILLEBRAND FACTOR | 97867 | 0% | 100% | 2 | Search SOLID+PHASE+VON+WILLEBRAND+FACTOR | Search SOLID+PHASE+VON+WILLEBRAND+FACTOR |
5 | PLATELETS | 89690 | 24% | 1% | 149 | Search PLATELETS | Search PLATELETS |
6 | PLASMA FIBRINOGEN | 68323 | 1% | 16% | 9 | Search PLASMA+FIBRINOGEN | Search PLASMA+FIBRINOGEN |
7 | ELEVATED PLATELET COUNT | 65243 | 0% | 67% | 2 | Search ELEVATED+PLATELET+COUNT | Search ELEVATED+PLATELET+COUNT |
8 | HYPERFIBRINOGENEMIA | 62905 | 1% | 21% | 6 | Search HYPERFIBRINOGENEMIA | Search HYPERFIBRINOGENEMIA |
9 | TCIPA | 55047 | 0% | 38% | 3 | Search TCIPA | Search TCIPA |
10 | ALPHA GRANULES | 50498 | 1% | 13% | 8 | Search ALPHA+GRANULES | Search ALPHA+GRANULES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BAMBACE, NM , HOLMES, CE , (2011) THE PLATELET CONTRIBUTION TO CANCER PROGRESSION.JOURNAL OF THROMBOSIS AND HAEMOSTASIS. VOL. 9. ISSUE 2. P. 237 -249 | 60 | 38% | 146 |
2 | TESFAMARIAM, B , (2016) INVOLVEMENT OF PLATELETS IN TUMOR CELL METASTASIS.PHARMACOLOGY & THERAPEUTICS. VOL. 157. ISSUE . P. 112 -119 | 36 | 59% | 5 |
3 | MENCZER, J , (2017) PREOPERATIVE ELEVATED PLATELET COUNT AND THROMBOCYTOSIS IN GYNECOLOGIC MALIGNANCIES.ARCHIVES OF GYNECOLOGY AND OBSTETRICS. VOL. 295. ISSUE 1. P. 9 -15 | 28 | 88% | 0 |
4 | PERISANIDIS, C , PSYRRI, A , COHEN, EE , ENGELMANN, J , HEINZE, G , PERISANIDIS, B , STIFT, A , FILIPITS, M , KORNEK, G , NKENKE, E , (2015) PROGNOSTIC ROLE OF PRETREATMENT PLASMA FIBRINOGEN IN PATIENTS WITH SOLID TUMORS: A SYSTEMATIC REVIEW AND META-ANALYSIS.CANCER TREATMENT REVIEWS. VOL. 41. ISSUE 10. P. 960 -970 | 42 | 55% | 5 |
5 | HENG, S , BENJAPIBAL, M , (2014) PREOPERATIVE THROMBOCYTOSIS AND POOR PROGNOSTIC FACTORS IN ENDOMETRIAL CANCER.ASIAN PACIFIC JOURNAL OF CANCER PREVENTION. VOL. 15. ISSUE 23. P. 10231 -10236 | 24 | 96% | 2 |
6 | FELDING-HABERMANN, B , GAY, LJ , (2011) CONTRIBUTION OF PLATELETS TO TUMOUR METASTASIS.NATURE REVIEWS CANCER. VOL. 11. ISSUE 2. P. 123 -134 | 46 | 29% | 309 |
7 | YAN, M , LESYK, G , RADZIWON-BALICKA, A , JURASZ, P , (2014) PHARMACOLOGICAL REGULATION OF PLATELET FACTORS THAT INFLUENCE TUMOR ANGIOGENESIS.SEMINARS IN ONCOLOGY. VOL. 41. ISSUE 3. P. 370 -377 | 37 | 56% | 6 |
8 | BUERGY, D , WENZ, F , GRODEN, C , BROCKMANN, MA , (2012) TUMOR-PLATELET INTERACTION IN SOLID TUMORS.INTERNATIONAL JOURNAL OF CANCER. VOL. 130. ISSUE 12. P. 2747-2760 | 50 | 32% | 79 |
9 | HASSELBALCH, HC , (2014) THE PLATELET-CANCER LOOP IN MYELOPROLIFERATIVE CANCER. IS THROMBOCYTHEMIA AN ENHANCER OF CANCER INVASIVENESS AND METASTASIS IN ESSENTIAL THROMBOCYTHEMIA, POLYCYTHEMIA VERA AND MYELOFIBROSIS?.LEUKEMIA RESEARCH. VOL. 38. ISSUE 10. P. 1230 -1236 | 46 | 42% | 2 |
10 | LI, NL , (2016) PLATELETS IN CANCER METASTASIS: TO HELP THE "VILLAIN" TO DO EVIL.INTERNATIONAL JOURNAL OF CANCER. VOL. 138. ISSUE 9. P. 2078 -2087 | 40 | 35% | 4 |
Classes with closest relation at Level 1 |